Search

Your search keyword '"Nijland, Marcel"' showing total 381 results
Start Over Author "Nijland, Marcel"
381 results on '"Nijland, Marcel"'

2. Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry

Author

Brink, Mirian, Huisman, Francien, Meeuwes, Frederik O., van der Poel, Marjolein W. M., Kersten, Marie José, Wondergem, Mariëlle, Böhmer, Lara, Woei-A-Jin, F. J. Sherida H., Visser, Otto, Oostvogels, Rimke, Jansen, Patty M., Diepstra, Arjan, Snijders, Tjeerd J. F., Huls, Gerwin, Vermaat, Joost S. P., Plattel, Wouter J., and Nijland, Marcel

Published
2024
Full Text
View/download PDF

3. Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA

Author

Veltmaat, Nick, Zhong, Yujie, de Jesus, Filipe Montes, Tan, Geok Wee, Bult, Johanna A. A., Terpstra, Martijn M., Mutsaers, Pim G. N. J., Stevens, Wendy B. C., Mous, Rogier, Vermaat, Joost S. P., Chamuleau, Martine E. D., Noordzij, Walter, Verschuuren, Erik A. M., Kok, Klaas, Kluiver, Joost L., Diepstra, Arjan, Plattel, Wouter J., van den Berg, Anke, and Nijland, Marcel

Published
2023
Full Text
View/download PDF

5. A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients

Author

de Jonge, A. Vera, van Werkhoven, Erik, Dinmohamed, Avinash G., Nijland, Marcel, Zwinderman, Aeilko H., Bossuyt, Patrick M., Veldhuis, Martine S., Rutten, Emma G. G. M., Mous, Rogier, Vermaat, Joost S. P., Sandberg, Yorick, de Jongh, Eva, Bilgin, Yavuz M., Boersma, Rinske, Koene, Harry, Kersten, Marie José, de Jong, Daphne, and Chamuleau, Martine E. D.

Published
2023
Full Text
View/download PDF

6. Distinct peripheral T-cell and NK-cell profiles in HGBL-MYC/BCL2 vs patients with DLBCL NOS

Author

de Jonge, A. Vera, Duetz, Carolien, Bruins, Wassilis S. C., Korst, Charlotte L. B. M., Rentenaar, Rosa, Cosovic, Meliha, Eken, Merve, Twickler, Inoka, Nijland, Marcel, van der Poel, Marjolein W. M., de Heer, Koen, Klerk, Clara P. W., Strobbe, Leonie, Oosterveld, Margriet, Boersma, Rinske, Koene, Harry R., Roemer, Margaretha G. M., van Werkhoven, Erik, Chamuleau, Martine E. D., and Mutis, Tuna

Published
2024
Full Text
View/download PDF

7. R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial

Author

Chamuleau, Martine E D, Stenner, Frank, Chitu, Dana A, Novak, Urban, Minnema, Monique C, Geerts, Paul, Stevens, Wendy B C, Zenz, Thorsten, van Imhoff, Gustaaf W, Wu, Ka Lung, Demandt, Astrid M P, Kersten, Marie Jose, Terpstra, Wim E, Tick, Lidwine W, Deeren, Dries, Van Den Neste, Eric, Gregor, Michael, Veelken, Hendrik, Böhmer, Lara H, Caspar, Clemens B, Mutsaers, Pim, Refos, Jeannine M, Sewsaran, Robby, Fu, Liping, Seefat, Rianne L, Uyl-de Groot, Carin A, Dirnhofer, Stefan, Van Den Brand, Michiel, de Jong, Daphne, Nijland, Marcel, and Lugtenburg, Pieternella

Published
2023
Full Text
View/download PDF

8. Prognostic value of TARC and quantitative PET parameters in relapsed or refractory Hodgkin lymphoma patients treated with brentuximab vedotin and DHAP

Author

Driessen, Julia, Kersten, Marie José, Visser, Lydia, van den Berg, Anke, Tonino, Sanne H., Zijlstra, Josée M., Lugtenburg, Pieternella J., Morschhauser, Franck, Hutchings, Martin, Amorim, Sandy, Gastinne, Thomas, Nijland, Marcel, Zwezerijnen, Gerben J. C., Boellaard, Ronald, de Vet, Henrica C. W., Arens, Anne I. J., Valkema, Roelf, Liu, Roberto D. K., Drees, Esther E. E., de Jong, Daphne, Plattel, Wouter J., and Diepstra, Arjan

Published
2022
Full Text
View/download PDF

9. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

Author

Nanni, Cristina, Kobe, Carsten, Baeßler, Bettina, Baues, Christian, Boellaard, Ronald, Borchmann, Peter, Buck, Andreas, Buvat, Irène, Chapuy, Björn, Cheson, Bruce D, Chrzan, Robert, Cottereau, Ann-Segolene, Dührsen, Ulrich, Eikenes, Live, Hutchings, Martin, Jurczak, Wojciech, Kraeber-Bodéré, Françoise, Lopci, Egesta, Luminari, Stefano, MacLennan, Steven, Mikhaeel, N George, Nijland, Marcel, Rodríguez-Otero, Paula, Treglia, Giorgio, Withofs, Nadia, Zamagni, Elena, Zinzani, Pier Luigi, Zijlstra, Josée M, Herrmann, Ken, and Kunikowska, Jolanta

Published
2023
Full Text
View/download PDF

10. Epcoritamab + R-DHAX/C in transplant-eligible patients (pts) with high-risk relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).

Author

Karimi, Yasmin, primary, Abrisqueta, Pau, additional, de Vos, Sven, additional, Nijland, Marcel, additional, Offner, Fritz, additional, Osei-Bonsu, Kojo, additional, Rana, Ali, additional, Archer, Kimberly G., additional, Song, Yaou, additional, Cordoba, Raul, additional, and Falchi, Lorenzo, additional

Published
2024
Full Text
View/download PDF

11. Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysis

Author

Meeuwes, Frederik O., Brink, Mirian, van der Poel, Marjolein W.M., Kersten, Marie José, Wondergem, Mariëlle, Mutsaers, Pim G.N.J., Böhmer, Lara, Woei-A-Jin, Sherida, Visser, Otto, Oostvogels, Rimke, Jansen, Patty M., Diepstra, Arjan, Snijders, Tjeerd J.F., Plattel, Wouter J., Huls, Gerwin A., Vermaat, Joost S.P., and Nijland, Marcel

Published
2022
Full Text
View/download PDF

12. Optimal Timing of a Physical Exercise Intervention to Improve Cardiorespiratory Fitness: During or After Chemotherapy

Author

van der Schoot, Gabriela G.F., Ormel, Harm L., Westerink, Nico-Derk L., May, Anne M., Elias, Sjoerd G., Hummel, Yoran M., Lefrandt, Joop D., van der Meer, Peter, van Melle, Joost P., Poppema, Boelo J., Stel, Joyce M.A., van der Velden, Annette W.G., Vrieling, Aline H., Wempe, Johan B., ten Wolde, Marcel G., Nijland, Marcel, de Vries, Elisabeth G.E., Gietema, Jourik A., and Walenkamp, Annemiek M.E.

Published
2022
Full Text
View/download PDF

13. Impact of etoposide and ASCT on survival among patients aged

Author

Brink, Mirian, Meeuwes, Frederik O., van der Poel, Marjolein W.M., Kersten, Marie José, Wondergem, Mariëlle, Mutsaers, Pim G.N.J., Böhmer, Lara H., Woei-A-Jin, F. J. Sherida H., Visser, Otto, Oostvogels, Rimke, Jansen, Patty M., Plattel, Wouter, Huls, Gerwin A., Vermaat, Joost S.P., and Nijland, Marcel

Published
2022
Full Text
View/download PDF

16. Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype

Author

de Groen, Ruben A.L., van Eijk, Ronald, Böhringer, Stefan, van Wezel, Tom, Raghoo, Richard, Ruano, Dina, Jansen, Patty M., Briaire-de Bruijn, Inge, de Groot, Fleur A., Kleiverda, Karin, te Boome, Liane, Terpstra, Valeska, Levenga, Henriette, Nicolae, Alina, Posthuma, Eduardus F.M., Focke-Snieders, Isabelle, Hardi, Lizan, den Hartog, Wietske C.E., Bohmer, Lara H., Hogendoorn, Pancras C.W., van den Berg, Anke, Diepstra, Arjan, Nijland, Marcel, Lugtenburg, Pieternella J., Kersten, Marie José, Pals, Steven T., Veelken, Hendrik, Bovée, Judith V.M.G., Cleven, Arjen H.G., and Vermaat, Joost S.P.

Published
2021
Full Text
View/download PDF

17. Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

Author

Brink, Mirian, Kahle, Xaver U., Vermaat, Joost S.P., Zijlstra, Josee M., Chamuleau, Martine, Kersten, Marie José, Durmaz, Müjde, Plattel, Wouter J., Lugtenburg, Pieternella J., Stevens, Wendy, Mous, Rogier, de Vries, Elisabeth G.E., van der Poel, Marjolein W.M., Panday, Prashant V. Nannan, Huls, Gerwin, van Meerten, Tom, and Nijland, Marcel

Published
2021
Full Text
View/download PDF

18. Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Author

Bromberg, Jacoline E C, Issa, Samar, van der Holt, Bronno, van der Meulen, Matthijs, Dirven, Linda, Minnema, Monique C, Seute, Tatjana, Durian, Marc, Cull, Gavin, Poel, Marjolein W M van der, Stevens, Wendy B C, Zijlstra, Josee M, Brandsma, Dieta, Nijland, Marcel, Mason, Kylie D, Beeker, Aart, Abrahamse-Testroote, Martine C J, Bent, Martin J van den, Jong, Daphne de, and Doorduijn, Jeanette K

Published
2024
Full Text
View/download PDF

20. The Impact of Genetic Subtypes of Diffuse Large B-Cell Lymphoma for Outcome Prediction and Interpretation of FDG-PET treatment Response Monitoring

Author

Ylstra, Bauke, primary, Mendeville, Matias, additional, Janssen, Jurriaan, additional, Vries, G. Tjitske Los-de, additional, Dijk, Erik van, additional, Richter, Julia, additional, Nijland, Marcel, additional, Roemer, Margaretha, additional, Stathi, Phylicia, additional, Hijmering, Nathalie, additional, Bladergroen, Reno, additional, Pelaz, Diego, additional, Diepstra, Arjan, additional, Eertink, Corinne, additional, Burggraaff, Coreline, additional, Kim, Yongsoo, additional, Lugtenburg, Pieternella, additional, Berg, Anke van den, additional, Tzankov, Alexandar, additional, Dirnhofer, Stephan, additional, Duhrsen, Ulrich, additional, Hüttmann, Andreas, additional, Klapper, Wolfram, additional, Zijlstra-Baalbergen, Josée, additional, and de Jong, Daphne, additional

Published
2023
Full Text
View/download PDF

21. Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the Netherlands

Author

Meeuwes, Frederik O., primary, Brink, Mirian, additional, Plattel, Wouter, additional, Van der Poel, Marjolein W.M., additional, Kersten, Marie José, additional, Wondergem, Mariëlle, additional, Böhmer, Lara, additional, Woei-A-Jin, F.J. Sherida H., additional, Visser, Otto, additional, Oostvogels, Rimke, additional, Jansen, Patty M., additional, Neelis, Karen J., additional, Crijns, Anne P.G., additional, Daniëls, Laurien A., additional, Snijders, Tjeerd J.F., additional, Vermaat, Joost S.P., additional, Huls, Gerwin A., additional, and Nijland, Marcel, additional

Published
2023
Full Text
View/download PDF

25. IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status

Author

Merryman, Reid W., primary, Belada, David, additional, Sureda, Anna, additional, Leppä, Sirpa, additional, Vermaat, Joost S.P., additional, Holte, Harald, additional, Hutchings, Martin, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Christensen, Jacob Haaber, additional, Wahlin, Björn E., additional, Linton, Kim M., additional, Wang, Liwei, additional, Abbas, Aqeel, additional, Rana, Ali, additional, Quadri, Syed, additional, and Falchi, Lorenzo, additional

Published
2023
Full Text
View/download PDF

26. POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status

Author

Merryman, Reid W., primary, Belada, David, additional, Sureda, Anna, additional, Leppä, Sirpa, additional, Vermaat, Joost S.P., additional, Holte, Harald, additional, Hutchings, Martin, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Christensen, Jacob Haaber, additional, Wahlin, Björn E., additional, Linton, Kim M., additional, Wang, Liwei, additional, Abbas, Aqeel, additional, Rana, Ali, additional, Quadri, Syed, additional, and Falchi, Lorenzo, additional

Published
2023
Full Text
View/download PDF

27. P1159: INFERIOR OUTCOME OF FRAIL AND UNFIT PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH ATTENUATED R-CHOP

Author

Al-Sarayfi, Diana, primary, Brink, Mirian, additional, Chamuleau, Martine E. D., additional, Brouwer, Rolf, additional, van Rijn, Roos, additional, Issa, Djamila, additional, Deenik, Wendy, additional, Huls, Gerwin, additional, Mous, Rogier, additional, Vermaat, Joost S.P., additional, Zijlstra, Josee M., additional, van Meerten, Tom, additional, and Nijland, Marcel, additional

Published
2023
Full Text
View/download PDF

28. S222: EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN PATIENTS WITH HIGH-RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS

Author

Sureda, Anna, primary, Falchi, Lorenzo, additional, Leppa, Sirpa, additional, Vermaat, Joost, additional, Holte, Harald, additional, Hutchings, Martin, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Merryman, Reid W., additional, Christensen, Jacob Haaber, additional, Wahlin, Bjorn, additional, Linton, Kim, additional, Wang, Liwei, additional, Abbas, Aqeel, additional, Rana, Ali, additional, Quadri, Syed, additional, and Belada, David, additional

Published
2023
Full Text
View/download PDF

32. Table S1 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Author

Bouwstra, Renée, primary, He, Yuan, primary, de Boer, Janneke, primary, Kooistra, Hilde, primary, Cendrowicz, Ewa, primary, Fehrmann, Rudolf S.N., primary, Ammatuna, Emanuele, primary, zu Eulenburg, Christine, primary, Nijland, Marcel, primary, Huls, Gerwin, primary, Bremer, Edwin, primary, and van Meerten, Tom, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure Legends from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Author

Bouwstra, Renée, primary, He, Yuan, primary, de Boer, Janneke, primary, Kooistra, Hilde, primary, Cendrowicz, Ewa, primary, Fehrmann, Rudolf S.N., primary, Ammatuna, Emanuele, primary, zu Eulenburg, Christine, primary, Nijland, Marcel, primary, Huls, Gerwin, primary, Bremer, Edwin, primary, and van Meerten, Tom, primary

Published
2023
Full Text
View/download PDF

34. Data from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Author

Bouwstra, Renée, primary, He, Yuan, primary, de Boer, Janneke, primary, Kooistra, Hilde, primary, Cendrowicz, Ewa, primary, Fehrmann, Rudolf S.N., primary, Ammatuna, Emanuele, primary, zu Eulenburg, Christine, primary, Nijland, Marcel, primary, Huls, Gerwin, primary, Bremer, Edwin, primary, and van Meerten, Tom, primary

Published
2023
Full Text
View/download PDF

35. Figure S1, S2, S3, S4 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Author

Bouwstra, Renée, primary, He, Yuan, primary, de Boer, Janneke, primary, Kooistra, Hilde, primary, Cendrowicz, Ewa, primary, Fehrmann, Rudolf S.N., primary, Ammatuna, Emanuele, primary, zu Eulenburg, Christine, primary, Nijland, Marcel, primary, Huls, Gerwin, primary, Bremer, Edwin, primary, and van Meerten, Tom, primary

Published
2023
Full Text
View/download PDF

37. FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.

Author

Ginkel, Martha S van, Arends, Suzanne, van der Vegt, Bert, Nijland, Marcel, Spijkervet, Fred K L, Vissink, Arjan, Kroese, Frans G M, Glaudemans, Andor W J M, and Bootsma, Hendrika

Subjects
SALIVARY gland radiography, STATISTICS, PREDICTIVE tests, POSITRON emission tomography computed tomography, QUANTITATIVE research, MANN Whitney U Test, FISHER exact test, T-test (Statistics), RADIOPHARMACEUTICALS, DESCRIPTIVE statistics, CHI-squared test, DEOXY sugars, LYMPHOMAS, SJOGREN'S syndrome, RECEIVER operating characteristic curves, SENSITIVITY & specificity (Statistics), DATA analysis, DATA analysis software
Abstract

Objectives To assess the usefulness of [18F]-fluorodeoxyglucose (FDG)-PET/CT (i) to discriminate between primary SS (pSS) patients with and without lymphomas and (ii) to evaluate systemic disease activity in pSS. Methods ACR-EULAR-positive pSS patients who underwent FDG-PET/CT were included. Scans were visually evaluated and quantitative analysis was performed by measuring standardized uptake values (SUV) of salivary and lacrimal glands and systemic regions. Receiver operating characteristic curve analyses were performed to find SUV cut-off values to discriminate between lymphoma and non-lymphoma. Results Of the 70 included patients, 26 were diagnosed with a pSS-associated lymphoma, mostly of the mucosa-associated lymphoid tissue type (23/26). Lymphoma patients showed higher FDG uptake in the parotid and submandibular glands, and more frequently showed presence of nodular lung lesions, compared with non-lymphoma patients. The accuracy of the maximum SUV (SUVmax) in the parotid and submandibular gland to predict lymphoma diagnosis was good, with optimal cut-off points of 3.1 and 2.9. After combining these three visual and quantitative findings (nodular lung lesions, parotid SUVmax > 3.1 and submandibular SUVmax > 2.9), sensitivity was 92% when at least one of the three features were present, and specificity was 91% in case at least two features were present. Furthermore, FDG-PET/CT was able to detect systemic manifestations in pSS patients, mostly involving lymph nodes, entheses and lungs. Conclusions FDG-PET/CT can assist in excluding pSS-associated lymphomas in patients without PET abnormalities, possibly leading to a decrease of invasive biopsies in suspected lymphoma patients. Furthermore, FDG-PET/CT is able to detect systemic manifestations in pSS and can guide to the best biopsy location. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

40. R-CODOX-M/R-IVA Versus DA-EPOCH-R in Patients with Newly Diagnosed Burkitt Lymphoma. Final Results of A Multicenter Randomized HOVON/SAKK Trial

Author

Chamuleau, Martine, primary, Stenner, Frank, additional, Chitu, Dana, additional, Novak, Urban, additional, Minnema, Monique, additional, Geerts, Paul, additional, Stevens, Wendy, additional, Zenz, Thorsten, additional, van Imhoff, Gustaaf, additional, Wu, Ka Lung, additional, Demandt, Astrid, additional, Kersten, Marie Jose, additional, Terpstra, Wim, additional, Tick, Lidwine, additional, Deeren, Dries, additional, Van Den Neste, Eric, additional, Gregor, Michael, additional, Veelken, Joan Hendrik, additional, Bohmer, Lara, additional, Clemens, Caspar, additional, Mutsaers, Pim G. N. J., additional, Refos, Jeannine, additional, Sewsaran, Robby, additional, Fu, Liping, additional, Seefat, Rianne, additional, Uyl-de Groot, Carin, additional, Dirnhofer, Prof. Dr. Stefan, additional, Van Den Brand, Michiel, additional, de Jong, Daphne, additional, Nijland, Marcel, additional, and Lugtenburg, Pieternella, additional

Published
2023
Full Text
View/download PDF

41. Subcutaneous Epcoritamab + R-Dhax/C in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Eligible for Autologous Stem Cell Transplant: Updated Phase 1/2 Results

Author

Abrisqueta, Pau, primary, Cordoba, Raul, additional, Falchi, Lorenzo, additional, de Vos, Sven, additional, Nijland, Marcel, additional, Offner, Fritz, additional, Wu, Jun, additional, Bykhovski, Irina, additional, Wang, Liwei, additional, Rana, Ali, additional, and Phillips, Tycel, additional

Published
2022
Full Text
View/download PDF

42. Outcome of Transformed Marginal Zone Lymphoma: A Population Based Study

Author

Bult, Johanna A.A., primary, Huisman, Francien, additional, Zhong, Yujie, additional, Veltmaat, Nick, additional, Tonino, Sanne, additional, Vermaat, Joost S.P., additional, Chamuleau, Martine E.D., additional, Diepstra, Arjan, additional, Plattel, Wouter J., additional, Van Den Berg, Anke, additional, Brink, Mirian, additional, and Nijland, Marcel, additional

Published
2022
Full Text
View/download PDF

44. Polyostotic DLBCL Is Characterized By a NF-Κb Pathway Affecting Molecular Profile and Superior Survival

Author

De Groen, Ruben A.L., primary, De Groot, Fleur A, additional, De Haan, Lorraine M., additional, van Wezel, Tom, additional, Noordenbos, Troy, additional, Boehringer, Stefan, additional, Van Eijk, Ronald, additional, Raghoo, Richard, additional, Ruano, Dina, additional, Sijs-Szabo, Aniko, additional, te Boome, Liane, additional, Terpstra, Valeska, additional, Levenga, Henriette, additional, Nicolae, Aline, additional, Posthuma, Ward, additional, Focke-Snieders, Isabelle, additional, Hardi, Lizan, additional, den Hartog, Wietske, additional, Böhmer, Lara H., additional, Van Den Berg, Anke, additional, Mutseaers, Pim, additional, Van Der Poel, Marjolein W.M., additional, Abdul Hamid, Myrurgia, additional, Woei-a-Jin, F.J. Sherida H., additional, Janssens, Ann, additional, Tousseyn, Thomas, additional, Bovée, Judith, additional, Veelken, Hendrik, additional, Pals, Steven T, additional, Diepstra, Arjan, additional, Nijland, Marcel, additional, Kersten, Marie José, additional, Jansen, Patty M., additional, Cleven, Arjen, additional, and Vermaat, Joost S.P., additional

Published
2022
Full Text
View/download PDF

45. Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update

Author

Falchi, Lorenzo, primary, Abrisqueta, Pau, additional, Nijland, Marcel, additional, Leppä, Sirpa, additional, Hutchings, Martin, additional, Holte, Harald, additional, Merryman, Reid W, additional, Lugtenburg, Pieternella, additional, de Vos, Sven, additional, Cheah, Chan Y., additional, Christensen, Jacob Haaber, additional, Arcaini, Luca, additional, Drott, Kristina, additional, Hellström, Mats, additional, Leslie, Lori A., additional, Vitolo, Umberto, additional, Rana, Ali, additional, Abbas, Aqeel, additional, Wang, Liwei, additional, Dinh, Minh, additional, and Belada, David, additional

Published
2022
Full Text
View/download PDF

46. Immune Profiling of Double and Triple Hit High Grade B Cell Lymphoma Patients Treated with DA-EPOCH Reveals Activation of T Cells and Reduced T Cell Exhaustion

Author

de Jonge, A.Vera, primary, Duetz, Carolien, additional, Bruins, Wassilis S.C., additional, van Werkhoven, Erik D., additional, Nijland, Marcel, additional, Van Der Poel, Marjolein W.M., additional, de Heer, Koen, additional, Klerk, Clara P.W., additional, Sandberg, Yorick, additional, Fijnheer, Rob, additional, Mutseaers, Pim, additional, Issa, Djamila E., additional, Böhmer, Lara H., additional, Van Kampen, Roel J.W., additional, Visser, Otto J., additional, de Jong, Daphne, additional, Zijlstra, Josée M., additional, Mutis, Tuna, additional, and Chamuleau, Martine E.D., additional

Published
2022
Full Text
View/download PDF

47. Genomic Landscaping of Post-Transplant Lymphoproliferative Disorders Using Circulating Tumor DNA

Author

Veltmaat, Nick, primary, Tan, Geok Wee, additional, Bult, Johanna A.A., additional, Zhong, Yujie, additional, Plattel, Wouter J., additional, Mous, Rogier, additional, Mutsaers, Pim, additional, Stevens, Wendy B.C., additional, Vermaat, Joost S.P., additional, Chamuleau, Martine E.D., additional, Diepstra, Arjan, additional, Van Den Berg, Anke, additional, Montes De Jesus, Filipe, additional, and Nijland, Marcel, additional

Published
2022
Full Text
View/download PDF

48. Consolidation Improves Survival in Primary Central Nervous System Lymphoma without Preference for Type of High-Dose Methotrexate-Based Induction Treatment Regimen

Author

De Groot, Fleur A, primary, Doorduijn, Jeanette K., additional, Brink, Mirian, additional, De Groen, Ruben A.L., additional, De Haan, Lorraine M., additional, Noordenbos, Troy, additional, Sijs-Szabo, Aniko, additional, Lam, King Hong, additional, Diepstra, Arjan, additional, te Boome, Liane, additional, Terpstra, Valeska, additional, Böhmer, Lara H., additional, Zijlstra, Josée M., additional, Koens, Lianne, additional, Durian, Marc, additional, Oudshoorn, Mirjam A., additional, Veelken, Hendrik, additional, Van Der Poel, Marjolein W.M., additional, Abdul Hamid, Myrurgia, additional, Stevens, Wendy B.C., additional, van Rooij, J L.M, additional, Oostvogels, Rimke, additional, Neelis, Karen J., additional, van den Brand, Michiel, additional, Woei-a-Jin, F.J. Sherida H., additional, Tousseyn, Thomas, additional, Dierickx, Daan, additional, Jansen, Patty M., additional, Kersten, Marie Jose, additional, Bromberg, Jacoline, additional, Nijland, Marcel, additional, and Vermaat, Joost S.P., additional

Published
2022
Full Text
View/download PDF

49. Plasma Extracellular Vesicle-Associated microRNAs for Early Response Prediction in Patients with High-Grade B-Cell Lymphoma

Author

Wang, Steven, primary, Drees, Esther E.E., additional, Gómez-Martín, Cristina, additional, De Jonge, A., additional, van Eijndhoven, Monique, additional, Groenewegen, Nils, additional, Veldt-Verkuijlen, Sandra, additional, Nijland, Marcel, additional, Van Der Poel, Marjolein W.M., additional, Sandberg, Yorick, additional, van Rijn, Rozemarijn, additional, Mutsaers, Pim, additional, Vergote, Vibeke K.J., additional, Kersten, Marie José, additional, Bilgin, Yavuz M., additional, Stevens, Wendy B.C., additional, Durian, Marc, additional, Snijders, Tjeerd J.F., additional, de Jong, Daphne, additional, Zijlstra, Josée M., additional, Chamuleau, Martine E.D., additional, and Pegtel, Dirk Michiel, additional

Published
2022
Full Text
View/download PDF

50. Special Anatomical Subtypes of Diffuse Large B-Cell Lymphoma Have Distinct Tumor Microenvironments

Author

Noordenbos, Troy, primary, De Groot, Fleur A, additional, De Groen, Ruben A.L., additional, De Haan, Lorraine M., additional, Krog, Ricki T., additional, Sijs-Szabo, Aniko, additional, Griffioen, Marieke, additional, de Groot, Rosa, additional, Heemskerk, Mirjam H.M., additional, Ijsselsteijn, Marieke E., additional, Terpstra, Valeska, additional, Nijland, Marcel, additional, Mutseaers, Pim, additional, Chamuleau, Martine E.D., additional, Kersten, Marie Jose, additional, Diepstra, Arjan, additional, Bovée, Judith, additional, Jansen, Patty M., additional, De Miranda, Noel F.C.C., additional, and Vermaat, Joost S.P., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results